Clinical Trial Update: A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II clinical trial evaluating cytarabine (Ara-C) in men with androgen-independent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cytarabine (Ara-C) (cytarabine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED